We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Hospital-Acquired Anemia Affects One-Third of Patients

By LabMedica International staff writers
Posted on 31 May 2017
One in three patients hospitalized for medical problems experience hospital-acquired anemia (HAA), a drop in hematocrit due to the hospitalization, claims a new study.

Conducted by researchers at the University of Texas Southwestern Medical Center and the Parkland Health and Hospital System, the observational cohort study reviewed 11,309 patients discharged between November 1, 2009 and October 30, 2010 from six Texas hospitals, examining the incidence, predictors, and post-discharge outcomes associated with HAA. Patients with anemia on admission or missing hematocrit values were excluded.

The results revealed that one-third of the patients developed HAA - 21.6% with mild HAA; 10.1% with moderate HAA; and 1.4% with severe HAA. The most severe form of HAA--defined as a hematocrit of 27% or less at the time of discharge--was independently associated with a 39% increase in odds of being readmitted or dying within 30 days after hospital discharge. The two strongest potentially modifiable predictors of developing moderate or severe HAA were length of stay and a major procedure. The study was published in the May 2017 issue of the Journal of Hospital Medicine.

“This is the first study of post-discharge adverse outcomes of hospital-acquired anemia among a diverse group of patients who were hospitalized for different reasons,” said lead author Anil Makam, MD, of UT Southwestern. “Reducing blood loss during major surgeries and reducing unnecessary testing during hospital stays may lower a patient's risk of developing severe hospital-acquired anemia, and potentially improve their recovery.”

“This study shines a spotlight on a very common but underappreciated risk of hospitalization, hospital-acquired anemia, which has traditionally been viewed as an incidental change in the red blood count of no significance,” said senior author Professor Ethan Halm, MD, MPH. “However, our results showed that hospital-acquired anemia was associated with worse clinical outcomes after leaving the hospital, so it needs to be taken more seriously.”

Hematocrit is the volume percentage of red blood cells (RBCs) in blood; it is normally 45% for men and 40% for women. It is considered an integral part of the complete blood count (CBC), together with hemoglobin concentration, white blood cell count, and platelet count. Anemia refers to an abnormally low hematocrit, which could indicate life-threatening diseases such as bleeding, leukemia, malnutrition, water intoxication, and more.


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Latest Hematology News

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy